This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications for funding to perform research leading to the development of new approaches to create devices/components with enhanced accuracy and less patient burden that will represent real advancements
credit:
regarding safety and effectiveness of glucose control technologies and their integration into open and closed loop hormone replacement systems.
Relevant Nonprofit Program Categories
Obtain Full Opportunity Text:http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-21-011.html
Additional Information of Eligibility:Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U. S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Full Opportunity Web Address:http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-21-011.htmlContact: Agency Email Description: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Agency Email: Date Posted: 2021-05-06
Application Due Date: Archive Date: 2022-11-12